The Senate Health, Education, Labor & Pensions Committee today held a hearing examining the administration’s blueprint to lower prescription drug prices. Health and Human Services Secretary Alex Azar testified on steps the agency is taking to implement the blueprint. For example, Azar noted, the Centers for Medicare & Medicaid Services recently unveiled updates to its drug-pricing dashboard and warned Medicare Part D plan sponsors that their contracts with pharmacies should not prevent the pharmacist from telling customers when they can get a better deal on a drug by paying cash; and the Food and Drug Administration also recently began publicly identifying drug companies suspected of blocking access to samples needed to test generic drugs. Among other actions, he said HHS is working to require drug companies to include their list price in their television commercials; give Medicare Part D plans market-based tools to negotiate better deals with drug companies; and “bring negotiation to Medicare Part B.”

Related News Articles

Headline
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., along with several other Democratic senators, yesterday introduced bills aimed at increasing…
Headline
Committee Chairman Richard Neal, D-Mass., and Ranking Member Kevin Brady, R-Texas, said they are committed to working on bipartisan reforms to lower drug…
Headline
The AHA, Federation of American Hospitals, and American Society of Health-System Pharmacists today convened a panel of experts on Capitol Hill to discuss how…
Headline
Nearly 50 health care and consumer groups, including the AHA, voiced their support for the Creating and Restoring Equal Access to Equivalent Samples Act as it…
Headline
The Senate Health, Education, Labor & Pensions Committee today held a hearing to examine how primary care affects health care costs and outcomes.
Headline
The Department of Health and Human Services’ Office of Inspector General yesterday proposed excluding from safe harbor protection under the Anti-Kickback…